Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

Fentanyl 4Analgesia 4Morphine 3Psychiatric Rehabilitation 2Oxycodone 2Music Therapy 2Ketamine 2Diclofenac 2oxycodone-acetaminophen 1chloroprocaine 1Uncertainty 1Therapeutics 1Sodium Bicarbonate 1Saline Solution 1Psychosocial Intervention 1Pregabalin 1Pharmacogenomic Testing 1Palliative Care 1Nutritional Support 1Methadone 1Ketorolac Tromethamine 1Ketorolac 1Imagery, Psychotherapy 1Hydromorphone 1Gelclair 1Early Intervention, Educational 1Dextromethorphan 1Cognitive Behavioral Therapy 1Celecoxib 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Baclofen × Lymphoid × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡